LVW Advisors’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $2.91M | Sell |
22,654
-1,590
| -7% | -$186K | 0.25% | 56 |
|
|
2026
Q1 | $2.92M | Sell |
24,244
-527
| -2% | -$60.8K | 0.28% | 48 |
|
|
2025
Q4 | $2.61M | Buy |
24,771
+5,239
| +27% | +$492K | 0.26% | 51 |
|
|
2025
Q3 | $1.64M | Buy |
19,532
+615
| +3% | +$50.7K | 0.17% | 78 |
|
|
2025
Q2 | $1.5M | Buy |
18,917
+4,358
| +30% | +$346K | 0.16% | 80 |
|
|
2025
Q1 | $1.31M | Buy |
14,559
+4,086
| +39% | +$381K | 0.16% | 81 |
|
|
2024
Q4 | $1.04M | Buy |
10,473
+2,653
| +34% | +$274K | 0.13% | 109 |
|
|
2024
Q3 | $888K | Buy |
7,820
+1,028
| +15% | +$122K | 0.11% | 125 |
|
|
2024
Q2 | $841K | Buy |
6,792
+328
| +5% | +$42.3K | 0.12% | 107 |
|
|
2024
Q1 | $853K | Buy |
6,464
+656
| +11% | +$80.9K | 0.14% | 109 |
|
|
2023
Q4 | $633K | Sell |
5,808
-927
| -14% | -$96.2K | 0.12% | 128 |
|
|
2023
Q3 | $693K | Sell |
6,735
-3,033
| -31% | -$327K | 0.14% | 94 |
|
|
2023
Q2 | $1.13M | Sell |
9,768
-5,118
| -34% | -$581K | 0.22% | 80 |
|
|
2023
Q1 | $1.58M | Sell |
14,886
-956
| -6% | -$103K | 0.31% | 72 |
|
|
2022
Q4 | $1.76M | Sell |
15,842
-630
| -4% | -$64.4K | 0.36% | 69 |
|
|
2022
Q3 | $1.42M | Sell |
16,472
-310
| -2% | -$27.7K | 0.32% | 64 |
|
|
2022
Q2 | $1.53M | Sell |
16,782
-76
| -0.5% | -$6.74K | 0.31% | 68 |
|
|
2022
Q1 | $1.38M | Buy |
16,858
+821
| +5% | +$64.7K | 0.23% | 72 |
|
|
2021
Q4 | $1.23M | Buy |
16,037
+424
| +3% | +$33.8K | 0.21% | 79 |
|
|
2021
Q3 | $1.17M | Buy |
15,613
+827
| +6% | +$62.9K | 0.2% | 79 |
|
|
2021
Q2 | $1.15M | Buy |
14,786
+5,932
| +67% | +$441K | 0.2% | 79 |
|
|
2021
Q1 | $651K | Buy |
8,854
+2,325
| +36% | +$172K | 0.13% | 122 |
|
|
2020
Q4 | $510K | Buy |
6,529
+389
| +6% | +$29.8K | 0.1% | 113 |
|
|
2020
Q3 | $486K | Buy |
6,140
+177
| +3% | +$13.9K | 0.11% | 109 |
|
|
2020
Q2 | $440K | Sell |
5,963
-223
| -4% | -$16.8K | 0.11% | 104 |
|
|
2020
Q1 | $454K | Buy |
6,186
+3,280
| +113% | +$258K | 0.12% | 93 |
|
|
2019
Q4 | $252K | Sell |
2,906
-1,313
| -31% | -$108K | 0.06% | 156 |
|
|
2019
Q3 | $339K | Buy |
4,219
+341
| +9% | +$27.3K | 0.08% | 119 |
|
|
2019
Q2 | $310K | Sell |
3,878
-6,425
| -62% | -$492K | 0.09% | 117 |
|
|
2019
Q1 | $818K | Buy |
10,303
+2,421
| +31% | +$181K | 0.22% | 72 |
|
|
2018
Q4 | $575K | Sell |
7,882
-12,627
| -62% | -$891K | 0.19% | 72 |
|
|
2018
Q3 | $1.39M | Buy |
20,509
+15
| +0.1% | +$956 | 0.39% | 53 |
|
|
2018
Q2 | $1.19M | Sell |
20,494
-883
| -4% | -$49.8K | 0.38% | 55 |
|
|
2018
Q1 | $1.11M | Sell |
21,377
-697
| -3% | -$37.6K | 0.34% | 57 |
|
|
2017
Q4 | $1.19M | Buy |
22,074
+5,657
| +34% | +$314K | 0.35% | 53 |
|
|
2017
Q3 | $1M | Buy |
+16,417
| New | +$995K | 0.4% | 51 |
|
|
2017
Q2 | – | Sell |
-3,457
| Closed | -$210K | – | 118 |
|
|
2017
Q1 | $210K | Sell |
3,457
-9,003
| -72% | -$546K | 0.08% | 120 |
|
|
2016
Q4 | $700K | Buy |
12,460
+486
| +4% | +$28.4K | 0.24% | 60 |
|
|
2016
Q3 | $713K | Buy |
11,974
+1,135
| +10% | +$66.4K | 0.23% | 58 |
|
|
2016
Q2 | $596K | Sell |
10,839
-3,922
| -27% | -$209K | 0.22% | 57 |
|
|
2016
Q1 | $745K | Sell |
14,761
-908
| -6% | -$44.5K | 0.24% | 56 |
|
|
2015
Q4 | $790K | Sell |
15,669
-399
| -2% | -$20.1K | 0.31% | 53 |
|
|
2015
Q3 | $757K | Sell |
16,068
-480
| -3% | -$25.5K | 0.35% | 55 |
|
|
2015
Q2 | $899K | Buy |
16,548
+172
| +1% | +$9.65K | 0.38% | 53 |
|
|
2015
Q1 | $898K | Sell |
16,376
-463
| -3% | -$26.2K | 0.43% | 49 |
|
|
2014
Q4 | $912K | Buy |
+16,839
| New | +$938K | 0.5% | 43 |
|
Other funds holding MRK
ECSS
LVW Advisors's MRK Position: Q2 2026 in Review
LVW Advisors reduced its Merck (MRK) stake by 6.6% in Q2 2026, selling an estimated $186K and leaving 22,654 shares worth $2.91M. The position accounts for 0.25% of the portfolio, ranked #56.
LVW Advisors first reported a position in MRK in Q4 2014 and has held it in 46 quarters since. The position peaked at $2.92M in Q1 2026. 1,867 funds tracked by Wall St. Rank hold MRK as of Q2 2026.
- LVW Advisors held 22,654 shares of Merck worth $2.91M as of Q2 2026.
- LVW Advisors sold 1,590 Merck shares in Q2 2026, an estimated $186K.
- Merck made up 0.25% of LVW Advisors's portfolio in Q2 2026, its #56 holding.
- LVW Advisors first reported a position in Merck in Q4 2014 and has held it in 46 quarters since.
- LVW Advisors's Merck position peaked at $2.92M in Q1 2026.
- 1,867 funds tracked by Wall St. Rank held Merck as of Q2 2026.
Based on LVW Advisors's 13F filing for Q2 2026, filed 15 Jul 2026.